The global law firm Jones Day announced today that products liability partner
Dana Baiocco and health care partner Travis F. Jackson have relocated to the
Boston office.
"Dana and Travis are outstanding practitioners in their respective fields of
products liability and health care. Their arrival is another important
step toward fulfilling our commitment to build a full-service law office here in
Boston," said office partner-in-charge Traci Lovitt.
Health care practice leader Kevin Lyles added, "We are excited that Travis
will be serving our health care clients from our new Boston office. He is a
first-rate lawyer and is on the cutting edge of the challenges facing the health
care industry."
Dana Baiocco, formerly of Jones
Day's Pittsburgh office, focuses her practice on products liability and mass
tort defense litigation and on aviation litigation and counseling. She is a
member of Jones Day's Product Response Team, a multidisciplinary group of Jones
Day lawyers prepared to respond in recall or crisis situations. A licensed
pilot, Ms. Baiocco is defense counsel for Parker Hannifin Corporation in its
aviation component part product litigation and is currently defending Yamaha in
its Rhino products liability litigation nationwide. In 2007, 2009, and 2010, she
was named by The Legal 500 as a leading U.S. lawyer in the product liability and
mass tort defense category for aerospace/aviation.
Travis Jackson, formerly of Jones
Day's Columbus office, covers all aspects of the state and federal regulation of
the health care industry in his practice, as well as tax and corporate planning
for tax-exempt organizations. He has served as counsel to health systems as well
as drug and device manufacturers in mergers and acquisitions and has structured
joint venture relationships among health care providers. Mr. Jackson has also
represented health systems in physician contracting matters, such as employment
agreements, hospital-based physician agreements, and medical director
agreements, and has assisted health care providers and drug and device
manufacturers with fraud and abuse and Stark Law compliance.